75 State Street
Floor 26
Boston, MA 02109
The company was incorporated under the laws of the State of Delaware in June 2006.
Amwell is traded on the New York Stock Exchange, under NYSE: AMWL.
Amwell does not currently pay dividends.
Investors should contact Amwell’s transfer agent listed below for records of the company’s shares.
| Website: | https://shareholder.broadridge.com/ |
| E-mail: | shareholder@broadridge.com |
| Telephone: | (877)-830-4936 or (720)-378-5591 |
| Mail: | Broadridge Corporate Issuer Solutions, Inc. P.O. Box 1342 Brentwood, NY 11717 |
PricewaterhouseCoopers LLP is Amwell’s independent auditor.
The latest press releases are available in Amwell's Newsroom.
Visit the Amwell website to learn more about our leadership and board of directors.
Visit the email alerts section of the investor relations site to sign up for alerts for new quarterly reports, events, or other SEC filings.
For more investor inquiries, email investors@amwell.com.
For media inquiries, email press@amwell.com.
Investor materials, including quarterly and annual reports, are available under the SEC filings page of the investor relations site as well as at SEC.gov.